Response: "The Signal and the Noise"-a response to Clayton et al. (2021).
Gender dysphoria
adolescence
hormones
Journal
Child and adolescent mental health
ISSN: 1475-357X
Titre abrégé: Child Adolesc Ment Health
Pays: England
ID NLM: 101142157
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
13
10
2021
accepted:
26
11
2021
pubmed:
21
12
2021
medline:
18
8
2022
entrez:
20
12
2021
Statut:
ppublish
Résumé
The purpose of this response is to clarify points about the steps we took in a systematic review of the literature and to reaffirm our findings.
Types de publication
Journal Article
Review
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
263-264Commentaires et corrections
Type : CommentOn
Type : CommentOn
Informations de copyright
© 2021 Association for Child and Adolescent Mental Health.
Références
Clayton, A., Malone, W.J., Clarke, P., Mason, J., & D’Angelo, R. (2021). Commentary: The Signal and the Noise-questioning the benefits of puberty blockers for youth with gender dysphoria-a commentary on Rew et al. (2021). Child Adolesc Ment Health, 27, 259-262.
Cooper, H. (2017). Research synthesis and meta-analysis: A step-by-step approach (5th edn). Los Angeles: Sage.
Costa, R., Dunsford, M., Skagerberg, E., Holt, V., Carmichael, P., & Colizzi, M. (2015). Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria. The Journal of Sexual Medicine, 12, 2206-2214.
Joseph, T., Ting, J., & Butler, G. (2019). The effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria: Findings from a large national cohort. Journal of Pediatric Endocrinology and Metabolism, 32, 1077-1081.
Klink, D., Caris, M., Heijboer, A., van Trotsenburg, M., & Rotteveel, J. (2015). Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross- sex hormone treatment in adolescents with gender dysphoria. The Journal of Clinical Endocrinology & Metabolism, 100, E270-E275.
National Institute for Health and Care Excellence (NICE). (2020). Evidence review: Gonadotrophin releasing hormone analogues for children and adolescents with gender dysphoria. Available from: http://evidence.nhs.uk.
Rew, L., Young, C., Monge, M., & Bogucka, R. (2021). Review: Puberty blockers for transgender and gender diverse youth--A critical review of the literature. Child and Adolescent Mental Health, 26, 3-14.
Turban, J.L., King, D., Carswell, J.M., & Keuroghlian, A.S. (2020). Pubertal suppression for transgender youth and risk of suicidal ideation. Pediatrics, 145, e20191725.